ORASURE TECHNOLOGIES INC (OSUR) Stock Fundamental Analysis
USA - NASDAQ:OSUR - US68554V1089 - Common Stock
2.37 USD
+0.04 (+1.72%)
We assign a fundamental rating of 2 out of 10 to OSUR. OSUR was compared to 189 industry peers in the Health Care Equipment & Supplies industry. While OSUR seems to be doing ok healthwise, there are quite some concerns on its profitability. OSUR has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year OSUR has reported negative net income.
OSUR had a negative operating cash flow in the past year.
In the past 5 years OSUR reported 4 times negative net income.
In multiple years OSUR reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of OSUR (-14.24%) is comparable to the rest of the industry.
With a decent Return On Equity value of -16.64%, OSUR is doing good in the industry, outperforming 62.43% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROIC | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
OSUR's Gross Margin of 40.41% is on the low side compared to the rest of the industry. OSUR is outperformed by 66.14% of its industry peers.
OSUR's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for OSUR so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
2. Health
2.1 Basic Checks
OSUR does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, OSUR has more shares outstanding
OSUR has more shares outstanding than it did 5 years ago.
The debt/assets ratio for OSUR has been reduced compared to a year ago.
2.2 Solvency
OSUR has an Altman-Z score of 1.64. This is a bad value and indicates that OSUR is not financially healthy and even has some risk of bankruptcy.
OSUR has a Altman-Z score of 1.64. This is comparable to the rest of the industry: OSUR outperforms 56.61% of its industry peers.
A Debt/Equity ratio of 0.00 indicates that OSUR is not too dependend on debt financing.
With a decent Debt to Equity ratio value of 0.00, OSUR is doing good in the industry, outperforming 75.66% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 1.64 |
ROIC/WACCN/A
WACC8.74%
2.3 Liquidity
OSUR has a Current Ratio of 7.03. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
OSUR's Current ratio of 7.03 is amongst the best of the industry. OSUR outperforms 86.24% of its industry peers.
OSUR has a Quick Ratio of 6.20. This indicates that OSUR is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 6.20, OSUR belongs to the best of the industry, outperforming 87.30% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 |
3. Growth
3.1 Past
The earnings per share for OSUR have decreased strongly by -633.33% in the last year.
OSUR shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -43.95%.
Measured over the past years, OSUR shows a small growth in Revenue. The Revenue has been growing by 3.75% on average per year.
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
3.2 Future
OSUR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.37% yearly.
OSUR is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -4.62% yearly.
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for OSUR. In the last year negative earnings were reported.
Also next year OSUR is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
OSUR's earnings are expected to decrease with -41.36% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
5. Dividend
5.1 Amount
No dividends for OSUR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
NASDAQ:OSUR (11/11/2025, 9:52:41 AM)
2.37
+0.04 (+1.72%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners92.79%
Inst Owner Change-1.03%
Ins Owners4.8%
Ins Owner Change8.23%
Market Cap173.34M
Revenue(TTM)125.70M
Net Income(TTM)-60.24M
Analysts82.5
Price Target6.12 (158.23%)
Short Float %5.52%
Short Ratio7.11
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-11.19%
Min EPS beat(2)-24.34%
Max EPS beat(2)1.96%
EPS beat(4)1
Avg EPS beat(4)-41.25%
Min EPS beat(4)-142.2%
Max EPS beat(4)1.96%
EPS beat(8)4
Avg EPS beat(8)-77.07%
EPS beat(12)8
Avg EPS beat(12)182.53%
EPS beat(16)9
Avg EPS beat(16)134.8%
Revenue beat(2)1
Avg Revenue beat(2)-3.97%
Min Revenue beat(2)-8.84%
Max Revenue beat(2)0.89%
Revenue beat(4)2
Avg Revenue beat(4)-1.85%
Min Revenue beat(4)-8.84%
Max Revenue beat(4)0.89%
Revenue beat(8)6
Avg Revenue beat(8)-0.34%
Revenue beat(12)10
Avg Revenue beat(12)7.45%
Revenue beat(16)14
Avg Revenue beat(16)8.57%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)5%
EPS NQ rev (3m)-11.76%
EPS NY rev (1m)-3.57%
EPS NY rev (3m)-16.78%
Revenue NQ rev (1m)0.58%
Revenue NQ rev (3m)-14.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-5.16%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.38 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.48 | ||
| P/tB | 0.57 | ||
| EV/EBITDA | N/A |
EPS(TTM)-0.8
EYN/A
EPS(NY)-0.79
Fwd EYN/A
FCF(TTM)-0.6
FCFYN/A
OCF(TTM)-0.55
OCFYN/A
SpS1.72
BVpS4.95
TBVpS4.15
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -14.24% | ||
| ROE | -16.64% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 40.41% | ||
| FCFM | N/A |
ROA(3y)1.01%
ROA(5y)-1.05%
ROE(3y)0.93%
ROE(5y)-1.4%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.22%
GM growth 5Y-6.88%
F-Score2
Asset Turnover0.3
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 36.29% | ||
| Cap/Sales | 2.97% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 7.03 | ||
| Quick Ratio | 6.2 | ||
| Altman-Z | 1.64 |
F-Score2
WACC8.74%
ROIC/WACCN/A
Cap/Depr(3y)167.19%
Cap/Depr(5y)244.45%
Cap/Sales(3y)7.03%
Cap/Sales(5y)11.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-633.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-216.67%
EPS Next Y-241.31%
EPS Next 2Y-73.8%
EPS Next 3Y-41.36%
EPS Next 5Y25.37%
Revenue 1Y (TTM)-43.95%
Revenue growth 3Y-7.36%
Revenue growth 5Y3.75%
Sales Q2Q%-32.14%
Revenue Next Year-34.82%
Revenue Next 2Y-17.54%
Revenue Next 3Y-9.82%
Revenue Next 5Y-4.62%
EBIT growth 1Y-539.73%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-100.55%
EBIT Next 3Y14.36%
EBIT Next 5Y25.91%
FCF growth 1Y-157.36%
FCF growth 3YN/A
FCF growth 5Y117%
OCF growth 1Y-148.56%
OCF growth 3YN/A
OCF growth 5Y22.81%
ORASURE TECHNOLOGIES INC / OSUR FAQ
What is the ChartMill fundamental rating of ORASURE TECHNOLOGIES INC (OSUR) stock?
ChartMill assigns a fundamental rating of 2 / 10 to OSUR.
Can you provide the valuation status for ORASURE TECHNOLOGIES INC?
ChartMill assigns a valuation rating of 0 / 10 to ORASURE TECHNOLOGIES INC (OSUR). This can be considered as Overvalued.
Can you provide the profitability details for ORASURE TECHNOLOGIES INC?
ORASURE TECHNOLOGIES INC (OSUR) has a profitability rating of 1 / 10.
How financially healthy is ORASURE TECHNOLOGIES INC?
The financial health rating of ORASURE TECHNOLOGIES INC (OSUR) is 5 / 10.